Health Populi
AUGUST 12, 2021
For this annual report, Ordr analyzed security risks across over 500 deployments in healthcare, life sciences, retail, and manufacturing sectors for the 12 months June 2020 through June 2021. What’s unclear is how public policy and regulation can/will meet this moment. How to protect vulnerable groups of people?
Lexis Nexis
APRIL 12, 2021
Leading this business since 2018, Schoeller is responsible for delivering solutions across health plan, hospital and health system, pharmacy, and life science markets. We saw a 400% increase in the use of telemedicine. Some of the regulations have the NIST IAL criteria for authentication. JS: Absolutely.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Health Populi
JUNE 24, 2021
While telehealth and virtual care stood up quickly in 2020, questions remain about how it will/can persist in terms of funding, regulation, and business models. We also expect innovation to come out of pharma and biotech labs, and who will pay for new-new therapies?
HIT Consultant
MARCH 31, 2024
With an eye toward the future, healthcare and life sciences (HLS) organizations integrating CPQ are set to fundamentally alter traditional care delivery and management models. Any organization aiming to enhance operational efficiency and bolster patient care now sees a finely-tuned CPQ system as table stakes.
HIT Consultant
MARCH 9, 2023
Cristina Varner, Newfront, SVP National Life Science & Healthcare Practice Gone are the days when healthcare information was only available to us at the doctor’s office or through the office’s online portals, and that’s in part due to the rapidly growing popularity of wearable technology devices.
HIT Consultant
FEBRUARY 19, 2023
Regulators are now looking beyond clinical indications such as tumor size and delayed disease progression. These insights help regulators, payers and providers understand treatments through the eyes of the patient, including how symptoms and adverse events impact study medication adherence and quality of life across patient populations.
HIT Consultant
JULY 28, 2022
For instance, while 25% of the observed telemedicine companies received 10.0x Note that point estimates such as the mean or median can often be misleading on their own, as they do not convey the level of variability which can be very high such as in the Telemedicine and Population Health sectors. revenue at exit.
Expert insights. Personalized for you.
174 
Let's personalize your content